These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20171159)

  • 1. Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization.
    Borroto-Escuela DO; Narvaez M; Marcellino D; Parrado C; Narvaez JA; Tarakanov AO; Agnati LF; Díaz-Cabiale Z; Fuxe K
    Biochem Biophys Res Commun; 2010 Mar; 393(4):767-72. PubMed ID: 20171159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2 and 5-hydroxytryptamine 5-HT(₂A) receptors assemble into functionally interacting heteromers.
    Borroto-Escuela DO; Romero-Fernandez W; Tarakanov AO; Marcellino D; Ciruela F; Agnati LF; Fuxe K
    Biochem Biophys Res Commun; 2010 Oct; 401(4):605-10. PubMed ID: 20888323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homodimerization and internalization of galanin type 1 receptor in living CHO cells.
    Wirz SA; Davis CN; Lu X; Zal T; Bartfai T
    Neuropeptides; 2005 Dec; 39(6):535-46. PubMed ID: 16242774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coupling of 5-HT1A autoreceptors to inhibition of mitogen-activated protein kinase activation via G beta gamma subunit signaling.
    Kushwaha N; Albert PR
    Eur J Neurosci; 2005 Feb; 21(3):721-32. PubMed ID: 15733090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferential activation by galanin 1-15 fragment of the GalR1 protomer of a GalR1-GalR2 heteroreceptor complex.
    Borroto-Escuela DO; Narvaez M; Di Palma M; Calvo F; Rodriguez D; Millon C; Carlsson J; Agnati LF; Garriga P; Díaz-Cabiale Z; Fuxe K
    Biochem Biophys Res Commun; 2014 Sep; 452(3):347-53. PubMed ID: 25152404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the existence and function of galanin receptor heteromers in the central nervous system.
    Fuxe K; Borroto-Escuela DO; Romero-Fernandez W; Tarakanov AO; Calvo F; Garriga P; Tena M; Narvaez M; Millón C; Parrado C; Ciruela F; Agnati LF; Narvaez JA; Díaz-Cabiale Z
    Front Endocrinol (Lausanne); 2012; 3():127. PubMed ID: 23112793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific oligomerization of the 5-HT1A receptor in the plasma membrane.
    Woehler A; Wlodarczyk J; Ponimaskin EG
    Glycoconj J; 2009 Aug; 26(6):749-56. PubMed ID: 18853255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes.
    Wang S; Hashemi T; Fried S; Clemmons AL; Hawes BE
    Biochemistry; 1998 May; 37(19):6711-7. PubMed ID: 9578554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of 5-HT1A receptor-dependent cell survival by cAMP/protein kinase A: role of protein phosphatase 2A and Bax.
    Hsiung SC; Tin A; Tamir H; Franke TF; Liu KP
    J Neurosci Res; 2008 Aug; 86(10):2326-38. PubMed ID: 18459133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and differential regulation of galanin receptor subtypes in rat brain: effects of seizure activity.
    Lu X; Mazarati A; Sanna P; Shinmei S; Bartfai T
    Neuropeptides; 2005 Jun; 39(3):147-52. PubMed ID: 15944003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of serotonin 5-hydroxytryptamine-1A receptor activation using a phospho-extracellular-signal regulated kinase 2 sensor.
    Huwiler KG; Machleidt T; Chase L; Hanson B; Robers MB
    Anal Biochem; 2009 Oct; 393(1):95-104. PubMed ID: 19539597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neuropeptide galanin as an in vivo modulator of brain 5-HT1A receptors: possible relevance for affective disorders.
    Ogren SO; Razani H; Elvander-Tottie E; Kehr J
    Physiol Behav; 2007 Sep; 92(1-2):172-9. PubMed ID: 17585970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin receptor activation leads to neurite outgrowth and neuronal survival.
    Fricker AD; Rios C; Devi LA; Gomes I
    Brain Res Mol Brain Res; 2005 Aug; 138(2):228-35. PubMed ID: 15925428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular determinants in the second intracellular loop of the 5-hydroxytryptamine-1A receptor for G-protein coupling.
    Kushwaha N; Harwood SC; Wilson AM; Berger M; Tecott LH; Roth BL; Albert PR
    Mol Pharmacol; 2006 May; 69(5):1518-26. PubMed ID: 16410407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational and experimental analysis of the transmembrane domain 4/5 dimerization interface of the serotonin 5-HT(1A) receptor.
    Gorinski N; Kowalsman N; Renner U; Wirth A; Reinartz MT; Seifert R; Zeug A; Ponimaskin E; Niv MY
    Mol Pharmacol; 2012 Sep; 82(3):448-63. PubMed ID: 22669805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of galanin receptor 1 and galanin receptor 2 activation in synaptic plasticity associated with 3',5'-cyclic AMP response element-binding protein phosphorylation in the dentate gyrus: studies with a galanin receptor 2 agonist and galanin receptor 1 knockout mice.
    Badie-Mahdavi H; Lu X; Behrens MM; Bartfai T
    Neuroscience; 2005; 133(2):591-604. PubMed ID: 15885916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive and ligand-induced internalization of EGFP-tagged galanin R2 and Rl receptors in PC12 cells.
    Xia S; Kjaer S; Zheng K; Hu PS; Xu T; Hökfelt T; Xu ZQ
    Neuropeptides; 2005 Jun; 39(3):173-8. PubMed ID: 15885774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [125I]-Galanin binding in brain of wildtype, and galanin- and GalR1-knockout mice: strain and species differences in GalR1 density and distribution.
    Jungnickel SR; Gundlach AL
    Neuroscience; 2005; 131(2):407-21. PubMed ID: 15708483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational rearrangements and signaling cascades involved in ligand-biased mitogen-activated protein kinase signaling through the beta1-adrenergic receptor.
    Galandrin S; Oligny-Longpré G; Bonin H; Ogawa K; Galés C; Bouvier M
    Mol Pharmacol; 2008 Jul; 74(1):162-72. PubMed ID: 18403719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
    Gehlert DR; Schober DA; Morin M; Berglund MM
    Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.